Nathan Rubin
Impact in
- Dermatology top 5%
- Cutaneous lymphoproliferative disorders research
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Epidemiology 15
- Nonmelanoma Skin Cancer Studies 4
- Co-authors
- Amrita Goyal (7 shared papers)Kavita Goyal (5 shared papers)Daniel E. O’Leary (4 shared papers)Can Özütemiz (8 shared papers)Kimberly Bohjanen (4 shared papers)Jafar Golzarian (5 shared papers)Shamar Young (5 shared papers)Dorothy K. Hatsukami (6 shared papers)
- Journals
- Nicotine & Tobacco Research (4 papers)Diabetes (3 papers)Journal of the American Academy of Dermatology (3 papers)Neuroradiology (2 papers)Journal of the European Academy of Dermatology and Venereology (2 papers)
- Partner nations
- United StatesUnited KingdomTürkiye
In The Last Decade
Nathan Rubin
59 papers receiving 578 citations
Peers
Comparison fields: 5 of 87
- Dermatology 102
- Hepatology 59
- Epidemiology 175
- Otorhinolaryngology 19
- Physiology 97
Countries citing papers authored by Nathan Rubin
This map shows the geographic impact of Nathan Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Rubin more than expected).
Fields of papers citing papers by Nathan Rubin
This network shows the impact of papers produced by Nathan Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Rubin. The network helps show where Nathan Rubin may publish in the future.
Co-authors
The 25 scholars most cited alongside Nathan Rubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 36 | |
| 2 | 2019 | 34 | |
| 3 | 1988 | 32 | |
| 4 | 2018 | 31 | |
| 5 | 2020 | 27 | |
| 6 | 2021 | 26 | |
| 7 | 2020 | 25 | |
| 8 | 2020 | 23 | |
| 9 | 2019 | 21 | |
| 10 | 2020 | 20 | |
| 11 | 2019 | 18 | |
| 12 | 2019 | 17 | |
| 13 | 1987 | 17 | |
| 14 | 2022 | 14 | |
| 15 | 2022 | 13 | |
| 16 | 2021 | 13 | |
| 17 | 2019 | 12 | |
| 18 | 2019 | 12 | |
| 19 | 2020 | 11 | |
| 20 | 2020 | 10 |
About Nathan Rubin
Nathan Rubin is a scholar working on Epidemiology, Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology, having authored 60 papers that have together received 583 indexed citations. Recurring topics across this work include Smoking Behavior and Cessation (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Cutaneous lymphoproliferative disorders research (6 papers), MRI in cancer diagnosis (4 papers), Nonmelanoma Skin Cancer Studies (4 papers), Diabetes Management and Research (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Dermatology (102 citations), Hepatology (59 citations), Epidemiology (175 citations), Otorhinolaryngology (19 citations) and Physiology (97 citations). Nathan Rubin has collaborated with scholars based in United States, United Kingdom and Türkiye. Frequent co-authors include Amrita Goyal, Kavita Goyal, Daniel E. O’Leary, Can Özütemiz, Kimberly Bohjanen, Jafar Golzarian, Shamar Young, Dorothy K. Hatsukami, Robert Hong and Cheryl L. Reid. Their work appears in journals such as Nicotine & Tobacco Research, Diabetes, Journal of the American Academy of Dermatology, Neuroradiology and Journal of the European Academy of Dermatology and Venereology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.